Trial intelligence / Profile preview

Triptorelin in children with precocious puberty

NCT00909844Phase 3Completed

Sponsor
Ipsen
Start
Apr 2008
Primary completion
Apr 2015
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of triptorelin in precocious puberty, sponsored by Ipsen. Started Apr 2008; status: completed.

02

Drugs

triptorelin
03

Conditions

precocious puberty

Beyond the preview

Go deeper on NCT00909844.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00909844.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call